FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula III, in which Y denotes -C(O); R1 is C6 aryl, thiophenyl, thiazolyl; R2 in each case is independently selected from H and C1-C6 alkyl, with the proviso that at least one of R2 is C1-C6 alkyl; R3 is selected from H; R4 is selected from
; and R7 is selected from H, C1-C6 alkyl. Invention also relates to individual compounds, to a pharmaceutical composition and to use of a pharmaceutical composition.
EFFECT: obtaining novel compounds of formula III, which can be used for treating hepatitis B virus infection.
5 cl, 3 tbl, 64 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
METHOD FOR TREATMENT ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2277909C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, USING PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2317988C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2290179C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
PYRIMIDINES AND THEIR OPTIONS, AND THEIR APPLICATION | 2017 |
|
RU2760733C2 |
PYRIMIDINES, THEIR OPTIONS AND APPLICATION | 2017 |
|
RU2761439C2 |
NEW SULPHONAMIDE CARBOXAMIDE COMPOUNDS | 2018 |
|
RU2808572C2 |
Authors
Dates
2021-02-04—Published
2015-12-30—Filed